Hong Kong Stocks Extend Gains Despite China's GDP Miss; Insilico Medicine Climbs

MT Newswires Live
07/15

Hong Kong stocks held their momentum Wednesday as stronger-than-expected Chinese industrial output and retail sales data offset concerns over the country's weakest quarterly economic growth in more than three years.

The Hang Seng Index rose 1.4%, or 340.37 points, to close at 24,681.10, while the Hang Seng China Enterprises Index gained 1%, or 81.30 points, to finish at 8,184.38.

China's economy expanded 4.3% year over year in the second quarter, slowing from 5% in the previous quarter and marking its weakest pace of growth since the fourth quarter of 2022.

However, June industrial output rose 5.3% from a year earlier, and retail sales increased 1%, with both figures exceeding analysts' expectations, suggesting resilience in economic activity.

In corporate news, Insilico Medicine (HKG:3696) advanced over 10% after entering a strategic alliance with Bora Pharmaceuticals (TPE:6472) to collaborate on AI-driven drug discovery and development.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10